top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Epeuropace

Methods and results Participants were recruited from a randomized sample of patients not diagnosed with AF but having relevant risk factors: age 65 years, ischaemic and/or valvular heart disease, ...

Europace, Atrial fibrillation, Luisa Benito, Blanca Coll-Vinent, Eva Gómez, David Martí, Joan Mitjavila, Ferran Torres, Òscar Miró, Antoni Sisó, Lluís Mont

Date : 01/11/2015 Item size : 213471 bytes
Epeuropace

Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals Conclusions Accumulated lifetime physical activity, ...

Europace, ATRIAL FIBRILLATION, Lluís Mont, David Tamborero, Roberto Elosua, Irma Molina, Blanca Coll-Vinent, Marta Sitges, Bárbara Vidal, Andrea Scalise, Alejandro Tejeira, Antonio Berruezo, ...

Date : 01/01/2008 Item size : 272167 bytes
Epeuropace

Introduction Since the advent of cardiac stimulators in the 1950s, their use has grown incessantly to reach a total of more than 3 million functioning pacemakers worldwide today.1 Their increasing ...

Europace, Pacing and resynchronization therapy, Benoit Hercé, Pierre Nazeyrollas, François Lesaffre, Raphael Sandras, Jean-Pierre Chabert, Angéline Martin, Sophie Tassan-Mangina, Huu Tri ...

Date : 01/01/2013 Item size : 227911 bytes
Epeuropace

[...]AF is commonly associated with a number of cardiac and non-cardiac risk factors including ischaemic heart disease, cardiac failure, valvular heart disease, hypertension, diabetes, alcohol abuse, ...

Europace, ATRIAL FIBRILLATION, Jaspal S. Taggar, Gregory Y.H. Lip

Date : 01/01/2008 Item size : 158808 bytes
Epeuropace

An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance Cardiac resynchronisation therapy ...

Europace, CLINICAL RESEARCH, Syed Y. Ahsan, Bunny Saberwal, Pier D. Lambiase, Sanjay Chaubey, Oliver R. Segal, Aerokondal B. Gopalamurugan, James McCready, Dominic P. Rogers, Martin D. Lowe, Anthony ...

Date : 01/05/2013
Epeuropace

Abstract Aims The comparison of patients with long-standing implantable cardioverter-defibrillators (ICDs) who have had or never have had appropriate therapy for ventricular arrhythmias may offer ...

Europace, Implantable Cardioverter-Defibrillators, José Dizon, Kimberly Chen, Samantha Dizon, Angelo Biviano, William Whang, Frederick Ehlert, Jesus Vazquez, Tamim Nazif, Hasan Garan

Date : 01/01/2011
Epeuropace

Abstract Aims Identification of risk factors for ventricular tachycardia/ventricular fibrillation (VT/VF) occurrence in patients with implantable cardioverter-defibrillators (ICD) is reasonable, ...

Europace, ICD, Gunnar Klein, Christoph Lissel, Anne-Catherine Fuchs, Ajmal Gardiwal, Hanno Oswald, Marcos deSousa, A. Maximilian Pichlmaier, Ralf Lichtinghagen, Heinz Geerlings, Peter Lippolt, ...

Date : 01/08/2006
Epeuropace

Whether these changes are due to AF itself or coexistent cardiovascular diseases remains a matter of debate. [...]in the present study, the differences in plasma levels of sP-sel, fibrinogen, and ...

Europace, CLINICAL RESEARCH, Ruibin Fu, Shulin Wu, Pingsheng Wu, Jian Qiu

Date : 01/01/2011
Epeuropace

Abstract Aims To develop a simple point score system that can accurately predict the optimal energy of initial rectilinear biphasic (RLB) waveform shock for cardioversion (DC) of persistent atrial ...

Europace, CARDIOVERSION, Sebastian Stec, Aleksander Gorecki, Beata Zaborska, Piotr Kulakowski

Date : 01/04/2006
Epeuropace

Permanent pacemakersurvivalrisk factors Aims To determine long-term time-related survival and evaluate risk factors for increased mortality in patients following their first permanent pacemaker ...

Europace, Regular Article, J. R. Pyatt, J. D. Somauroo, M. Jackson, A. D. Grayson, S. Osula, R. K. Aggarwal, R. G. Charles, D. T. Connelly

Date : 01/04/2002